2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson’s disease and schizophrenia

OBJECTIVES: Parkinson’s disease and schizophrenia are clinical scenarios that occur due to dopaminergic deficit and hyperactivity in the midbrain, respectively. Current pharmacological interventions for these two diseases therefore aim to restore normal dopamine levels in the midbrain. But during th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuropsychiatr Dis Treat
Egile Nagusiak: Gupta, Ashish Kumar, Kumar, Gaurav Khunger, Rani, Komal, Pokhriyal, Ruchika, Khan, Mohd Imran, Kumar, Domada Ratna, Goyal, Vinay, Tripathi, Manjari, Gupta, Rishab, Chadda, Rakesh Kumar, Vanamail, Perumal, Mohanty, Ashok Kumar, Hariprasad, Gururao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2019
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6488160/
https://ncbi.nlm.nih.gov/pubmed/31114209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S198559
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak